Effects of Olanzapine, Risperidone and Haloperidol on Sleep After a Single Oral Morning Dose in Healthy Volunteers

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2007 Jan 6

PMID 17205319

Citations 26

Authors

Sandra Gimenez

Susana Clos

Sergio Romero

Eva Grasa

Adelaida Morte

Manuel J Barbanoj

Affiliations

Soon will be listed here.

Abstract

Objectives: To compare the effects of typical and atypical antipsychotic drugs on sleep activity and subjective sleep quality.

Design: Randomised, double-blind, placebo-controlled, four-period cross-over, clinical trial was used to evaluate the effects of active treatments on objective and subjective sleep variables.

Setting: Sleep laboratory evaluation.

Participants: Twenty healthy young volunteers, both sexes.

Interventions: Single oral morning administrations of olanzapine 5 mg, risperidone 1 mg, haloperidol 3 mg and placebo.

Measurements And Results: Five polysomnographic nights were evaluated: one control night and one after each intervention. Significant increase in total sleep time, sleep efficiency, slow wave sleep (SWS) and rapid eye movement (REM) sleep with decreases in wake time were observed after olanzapine. Decreases in wake time, REM sleep and stage shifts together with increases in stage 2 were obtained after risperidone. Haloperidol showed only a tendency to increase sleep efficiency and stage 2 and to decrease wake time. Olanzapine showed decreases in power density in frequencies higher than 10 Hz during all sleep stages and in frequencies lower than 5 Hz range in SWS; decreases in the dynamics of spindle frequency activity (SFA) in the second and fourth non-rapid eye movement (NREM) episodes were also obtained. Risperidone presented increases in the 3.6-10.8 Hz frequency range in NREM sleep stages and in stage 2. Haloperidol also showed increases in NREM sleep stages and in stage 2, but these were in frequencies higher than 10 Hz, with increases in the dynamics of SFA in the first NREM episode. Only a significant improvement in subjective sleep quality was observed after olanzapine.

Conclusions: Antipsychotics showed different sleep changes as their neurochemical profiles were distinct. These changes were observed even when the drug was administered 15 h before going to bed.

Citing Articles

Altered Sleep Oscillations as Neurophysiological Biomarkers of Schizophrenia.

Mayeli A, Donati F, Ferrarelli F Adv Neurobiol. 2024; 40:351-383.

PMID: 39562451 DOI: 10.1007/978-3-031-69491-2_13.

A spectrum of altered non-rapid eye movement sleep in schizophrenia.

Kozhemiako N, Jiang C, Sun Y, Guo Z, Chapman S, Gai G Sleep. 2024; 48(2).

PMID: 39297495 PMC: 11807884. DOI: 10.1093/sleep/zsae218.

The Function of Sleep and the Treatment of Primary Insomnia.

Freund W, Weber F Dtsch Arztebl Int. 2023; 120(50):863-870.

PMID: 37942822 PMC: 10840130. DOI: 10.3238/arztebl.m2023.0228.

Sleep during and following critical illness: A narrative review.

Showler L, Abdelhamid Y, Goldin J, Deane A World J Crit Care Med. 2023; 12(3):92-115.

PMID: 37397589 PMC: 10308338. DOI: 10.5492/wjccm.v12.i3.92.

G-protein coupled receptors and synaptic plasticity in sleep deprivation.

Parmar S, Tadavarty R, Sastry B World J Psychiatry. 2021; 11(11):954-980.

PMID: 34888167 PMC: 8613756. DOI: 10.5498/wjp.v11.i11.954.

References

Taylor S, Tandon R, Shipley J, Eiser A . Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry. 1991; 30(9):904-12. DOI: 10.1016/0006-3223(91)90004-6. View

Sharpley A, Elliott J, Attenburrow M, Cowen P . Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors. Neuropharmacology. 1994; 33(3-4):467-71. DOI: 10.1016/0028-3908(94)90077-9. View

Janssen P, NIEMEGEERS C, Awouters F, SCHELLEKENS K, Megens A, Meert T . Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther. 1988; 244(2):685-93. View

Borbely A, Mattmann P, Loepfe M, STRAUCH I, Lehmann D . Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol. 1985; 4(3):189-94. View

Salin-Pascual R, Laurrabaquio M . Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry. 1999; 46(1):141-3. DOI: 10.1016/s0006-3223(98)00372-2. View

Sharpley A, Bhagwagar Z, Hafizi S, Whale W, Gijsman H, Cowen P . Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry. 2003; 64(2):192-6. DOI: 10.4088/jcp.v64n0212. View

Worrel J, Marken P, Beckman S, Ruehter V . Atypical antipsychotic agents: a critical review. Am J Health Syst Pharm. 2000; 57(3):238-55. DOI: 10.1093/ajhp/57.3.238. View

Viola A, Brandenberger G, Toussaint M, Bouhours P, Macher J, Luthringer R . Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clin Neurophysiol. 2002; 113(3):429-34. DOI: 10.1016/s1388-2457(02)00014-7. View

Feinberg I, Floyd T . Systematic trends across the night in human sleep cycles. Psychophysiology. 1979; 16(3):283-91. DOI: 10.1111/j.1469-8986.1979.tb02991.x. View

10.

Salin-Pascual R, Herrera-Estrella M, Galicia-Polo L, Rosas M, Brunner E . Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin. 2004; 56(3):345-50. View

11.

Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo J, Shipley J . Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry. 1998; 155(11):1600-2. DOI: 10.1176/ajp.155.11.1600. View

12.

Hori T, Sugita Y, Koga E, Shirakawa S, Inoue K, Uchida S . Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci. 2001; 55(3):305-10. DOI: 10.1046/j.1440-1819.2001.00810.x. View

13.

Akerstedt T, Hume K, Minors D, Waterhouse J . Good sleep--its timing and physiological sleep characteristics. J Sleep Res. 1998; 6(4):221-9. DOI: 10.1111/j.1365-2869.1997.00221.x. View

14.

Akerstedt , Hume , Minors , Waterhouse . The meaning of good sleep: a longitudinal study of polysomnography and subjective sleep quality. J Sleep Res. 1994; 3(3):152-158. DOI: 10.1111/j.1365-2869.1994.tb00122.x. View

15.

Aeschbach , Borbely . All-night dynamics of the human sleep EEG. J Sleep Res. 1993; 2(2):70-81. DOI: 10.1111/j.1365-2869.1993.tb00065.x. View

16.

Dugovic C, Wauquier A, Janssen P . Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat. Neuropharmacology. 1989; 28(12):1431-3. DOI: 10.1016/0028-3908(89)90023-3. View

17.

Saletu B, Anderer P, Kinsperger K, Grunberger J . Topographic brain mapping of EEG in neuropsychopharmacology--Part II. Clinical applications (pharmaco EEG imaging). Methods Find Exp Clin Pharmacol. 1987; 9(6):385-408. View

18.

Itil T, Gannon P, Hsu W, KLINGENBERG H . Digital computer analyzed sleep and resting EEG during haloperidol treatment. Am J Psychiatry. 1970; 127(4):462-71. DOI: 10.1176/ajp.127.4.462. View

19.

Sharpley A, Vassallo C, Cowen P . Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry. 2000; 47(5):468-70. DOI: 10.1016/s0006-3223(99)00273-5. View

20.

Nicholson A, Pascoe P . Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology. 1991; 30(4):367-72. DOI: 10.1016/0028-3908(91)90062-g. View